Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer

被引:25
作者
Honda, Kazufumi [1 ,2 ]
Srivastava, Sudhir [3 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Tokyo 1040045, Japan
[2] Japan Agcy Med Res & Dev AMED CREST, Tokyo 1000004, Japan
[3] NCI, Canc Prevent Div, Rockville, MD 20852 USA
关键词
apolipoprotein A2 isoforms; early detection for pancreatic cancer; National Cancer Institute Early Detection Research Network; NCI EDRN; plasma/serum biomarker; COHORT-CONSORTIUM PANSCAN; MONOCLONAL-ANTIBODY; POOLED-ANALYSIS; ADENOCARCINOMA; SERUM; BIOMARKER; DIAGNOSIS; PLASMA; GLYPICAN-1; POPULATION;
D O I
10.2217/bmm-2016-0209
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Given the low incidence of pancreatic cancer in the general population, screening of pancreatic cancer in the general population using invasive modalities is not feasible. Combination of invasive screening with noninvasive biomarkers for pancreatic cancer and its precancerous lesions has the potential to reduce mortality due to pancreatic cancer. In this review, we focus on biomarkers found in the blood that can indicate early-stage pancreatic cancer, and we discuss current strategies for screening for pancreatic cancer. We recently identified a unique alteration in apolipoprotein A2 isoforms in pancreatic cancer and its precancerous lesions, and we describe its clinical usefulness as a potential biomarker for the early detection and risk stratification of pancreatic cancer.
引用
收藏
页码:1197 / 1207
页数:11
相关论文
共 63 条
[1]   Anthropometric Measures, Body Mass Index, and Pancreatic Cancer A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan) [J].
Arslan, Alan A. ;
Helzlsouer, Kathy J. ;
Kooperberg, Charles ;
Shu, Xiao-Ou ;
Steplowski, Emily ;
Bueno-de-Mesquita, H. Bas ;
Fuchs, Charles S. ;
Gross, Myron D. ;
Jacobs, Eric J. ;
LaCroix, Andrea Z. ;
Petersen, Gloria M. ;
Stolzenberg-Solomon, Rachael Z. ;
Zheng, Wei ;
Albanes, Demetrius ;
Amundadottir, Laufey ;
Bamlet, William R. ;
Barricarte, Aurelio ;
Bingham, Sheila A. ;
Boeing, Heiner ;
Boutron-Ruault, Marie-Christine ;
Buring, Julie E. ;
Chanock, Stephen J. ;
Clipp, Sandra ;
Gaziano, J. Michael ;
Giovannucci, Edward L. ;
Hankinson, Susan E. ;
Hartge, Patricia ;
Hoover, Robert N. ;
Hunter, David J. ;
Hutchinson, Amy ;
Jacobs, Kevin B. ;
Kraft, Peter ;
Lynch, Shannon M. ;
Manjer, Jonas ;
Manson, JoAnn E. ;
McTiernan, Anne ;
McWilliams, Robert R. ;
Mendelsohn, Julie B. ;
Michaud, Dominique S. ;
Palli, Domenico ;
Rohan, Thomas E. ;
Slimani, Nadia ;
Thomas, Gilles ;
Tjonneland, Anne ;
Tobias, Geoffrey S. ;
Trichopoulos, Ditnitrios ;
Virtamo, Jarmo ;
Wolpin, Brian M. ;
Yu, Kai ;
Zeleniuch-Jacquotte, Anne .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (09) :791-802
[2]  
BLANCOVACA F, 1992, J LIPID RES, V33, P1785
[3]   Importance of Age of Onset in Pancreatic Cancer Kindreds [J].
Brune, Kieran A. ;
Lau, Bryan ;
Paimisano, Emily ;
Canto, Marcia ;
Goggins, Michael G. ;
Hruban, Ralph H. ;
Klein, Alison P. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02) :119-126
[4]   Probability of pancreatic cancer following diabetes: A population-based study [J].
Chari, ST ;
Leibson, CL ;
Rabe, KG ;
Ransom, J ;
De Andrade, M ;
Petersen, GM .
GASTROENTEROLOGY, 2005, 129 (02) :504-511
[5]   Detecting early pancreatic cancer: Problems and prospects [J].
Chari, Suresh T. .
SEMINARS IN ONCOLOGY, 2007, 34 (04) :284-294
[6]   Early Detection of Sporadic Pancreatic Cancer Summative Review [J].
Chari, Suresh T. ;
Kelly, Kimberly ;
Hollingsworth, Michael A. ;
Thayer, Sarah P. ;
Ahlquist, David A. ;
Andersen, Dana K. ;
Batra, Surinder K. ;
Brentnall, Teresa A. ;
Canto, Marcia ;
Cleeter, Deborah F. ;
Firpo, Matthew A. ;
Gambhir, Sanjiv Sam ;
Go, Vay Liang W. ;
Hines, O. Joe ;
Kenner, Barbara J. ;
Klimstra, David S. ;
Lerch, Markus M. ;
Levy, Michael J. ;
Maitra, Anirban ;
Mulvihill, Sean J. ;
Petersen, Gloria M. ;
Rhim, Andrew D. ;
Simeone, Diane M. ;
Srivastava, Sudhir ;
Tanaka, Masao ;
Vinik, Aaron I. ;
Wong, David .
PANCREAS, 2015, 44 (05) :693-712
[7]   Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker [J].
Diamandis, Eleftherios P. ;
Plebani, Mario .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (01) :E1-E2
[8]   Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro [J].
Ducreux, M. ;
Cuhna, A. Sa. ;
Caramella, C. ;
Hollebecque, A. ;
Burtin, P. ;
Goere, D. ;
Seufferlein, T. ;
Haustermans, K. ;
Van Laethem, J. L. ;
Conroy, T. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2015, 26 :V56-V68
[9]   Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling [J].
Ehmann, Michael ;
Felix, Klaus ;
Hartmann, Daniel ;
Schnolzer, Martina ;
Nees, Matthias ;
Vorderwulbecke, Sonja ;
Bogumil, Ralf ;
Buchler, Markus W. ;
Friess, Helmut .
PANCREAS, 2007, 34 (02) :205-214
[10]   The Early Detection Research Network's Specimen Reference Sets: Paving the Way for Rapid Evaluation of Potential Biomarkers [J].
Feng, Ziding ;
Kagan, Jacob ;
Pepe, Margaret ;
Thornquist, Mark ;
Rinaudo, Jo Ann ;
Dahlgren, Jackie ;
Krueger, Karl ;
Zheng, Yingye ;
Patriotis, Christos ;
Huang, Ying ;
Sorbara, Lynn ;
Thompson, Ian ;
Srivastava, Sudhir .
CLINICAL CHEMISTRY, 2013, 59 (01) :68-74